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A monoclonal antibody (Mab) against a synthetic peptide, SEDYGKDL, corresponding to one conserved 
sequence in the chicken e-fodrin repeats reacts in immunoblotting with avian c~-spectrin a d ~-fodrin, both 
mammalian spectrins and with mammalian c~-fodrin. This Mab also reacts with ~-actinin in both chicken 
and human cells. Our results confirm the previously detected structural homology between spectrins and 
~-actinin and implicate their common evolutionary origin. 
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1. INTRODUCTION 
Spectrin-like proteins have been identified in 
most non-erythroid cells [1-7]. Studies with an- 
tibodies raised to these proteins, fodrins, have sug- 
gested that in mammalian cells they are 
immunologically related to chicken erythroid o~- 
spectrin but not to mammalian spectrins [1,3,5,6]. 
On the other hand, it has also been suggested that 
avian o~-spectrin and mammalian ce-fodrin are the 
most conserved members of the spectrin family [8]. 
Comparison of the partial cDNA sequences of 
chicken smooth muscle c~-fodrin [9,10] and human 
ce-fodrin [11] to the corresponding amino acid se- 
quences of mammalian o~-spectrin [12] has shown 
that these three proteins are closely similar: All 
contain 106-amino-acid repeats; this appears to be 
a structural hallmark of spectrins (cf. [6,12]). 
Comparison of the primary sequences of o~- 
spectrin and ce-fodrin also revealed distinctly well 
conserved regions (cf. [9,10]). 
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Recently, it was shown by sequence comparison 
that chicken c~-actinin and oe-fodrin have con- 
siderable structural homology implicating their 
common evolutionary origin [14]. Here, we have 
continued to study this homology with a 
monoclonal antibody raised against a synthetic 
peptide, SEDYGKDL, which is a conserved se- 
quence in avian ce-fodrin. We show that this an- 
tibody reacts with distinct members of the spectrin 
family. Although any sequences identical to 
SEDYGKDL are not found in oz-actinin, the 
monoclonal antibody clearly also recognizes this 
molecule. 
2. MATERIALS AND METHODS 
2.1. Peptide synthesis 
The sequence of the synthetic peptide, 
SEDYGKDL (GC), was predicted from the partial 
cDNA sequence of the avian oL-fodrin gene and 
corresponds to nucleotides 48-70 [9]. The peptide 
was synthesized by the solid-phase method using a 
Vega Coupler (250C) peptide synthesizer and t-Boc 
chemistry [15]. The protected t-butyloxycarbonyl 
(t-Boc) amino acids and Boc-Cys (MBzl)-O-resin 
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(1.0 mM available amine/g resin) as solid-phase 
support were purchased from Peninsula 
Laboratories (Belmont, CA). Trifluoroacetic acid 
(TFA, Fluka, Buchs, Switzerland; 40°70 in CH2C12, 
v/v) was used to remove the t-Boc group from the 
resin-bound amino acid residues, and TFA-treated 
resin was neutralized by using triethanolamine 
(Merck, Darmstadt) (10% in CHzC1, v/v). 
Protected amino acids were coupled to free 
amino groups using an equimolar amount of 
diisopropylcarbodiimide (Aldrich-Chemie, Stein- 
heim). The efficiency of each coupling reaction 
was followed using the ninhydrin assay [16]. 
The additional Gly and Cys residues were added 
to the carboxy-terminus to facilitate coupling of 
the peptide to the carrier protein, ovalbumin 
(Sigma, St. Louis, MO). Coupling was carried out 
using m-maleimidobenzoyl N-hydroxysuccinimide 
ester (Sigma) as described by Liu et al. [17]. 
2.2. Monoclonal antibodies 
For in vitro monoclonal antibody production, 
spleen cells from Balb/c mice (1.7 x 10 v cells/ml) 
were incubated in the presence of free peptide 
(2/~g/ml) and macrophages in the thymus- 
conditioned medium for 5 days [18]. The immu- 
nized spleen cells were fused with myeloma cells by 
standard techniques [19]. Positive hybridomas, 
producing IgM-type antibodies, were selected by a 
solid-phase enzyme immunoassay using the 
ovalbumin-coupled peptide and human erythro- 
cyte spectrins, which were isolated from freshly 
made red blood cell ghosts [20] by the low ionic 
elution method [21]. One of the clones, IV12DG9, 
reacting strongly in both assays was further 
characterized. For comparison, we also raised 
monoclonal antibodies against purified chicken 
gizzard c~-actinin [22] by standard techniques. 
Cloning of the antibodies was performed manual- 
ly. The culture supernatant was used for ex- 
periments. 
sample buffer [22] the specimens were separated in 
6.5% slab gels [23]. Transfer onto nitrocellulose 
sheets was carried out according to T wbin et al. 
[24]. For immunostaining the sheets were exposed 
to the Mabs or to rabbit antibodies to calf lens 
fodrin [3,9]. After washing the sheets were exposed 
to peroxidase-coupled rabbit anti-mouse im- 
munoglobulins or swine anti-rabbit IgG (Dako- 
parts, Glostrup, Denmark). The peroxidase 
reaction was developed as in [24]. 
3. RESULTS 
In immunofluorescence, theIV12DG9 Mab gave 
a bright membrane-associated r activity in both 
human (fig.la) and chicken red blood cells 
(fig.lb). Immunoblotting revealed that in human 
red blood cells this Mab reacts strongly with both 
a~- and ~-spectrins (fig.2, lane 2) as well as with 
chicken o~-spectrin (fig.2, lane 4). In chicken 
fibroblasts, it not only detects the 240 kDa c~- 
fodrin (fig.2, lane 7), similarly to the antibodies 
against calf lens fodrin (fig.2, lane 8), but reacts 
with a prominent 100 kDa polypeptide. The latter 
can also be detected with an Mab to o~-actinin 
(fig.l, lanes 7,9). Similarly, in human fibroblasts 
(fig.2, lane 11) and other mammalian non- 
2.3. Polyacrylamide gel electrophoresis and 
immunoblotting 
For SDS-PAGE analysis cultured human and 
chicken embryonal fibroblasts, chicken embryo 
red blood cells, human red blood cells and various 
chicken embryo tissues (brain, muscle, and in- 
testine) were extracted in 0.5% Triton X-100 
(50 mM Tris-HCl, pH 7.4) at 0°C. After boiling in 
a 
Fig.1. Indirect immunofluorescence staining of 
methanol-fixed cytocentrifuge preparations of human 
(a) and chicken erythrocytes (b) with the IV12DG9 
antibody. Note the distinct membrane type of staining in 
both types of erythrocytes, x 800. 
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erythroid cells, the IV12DG9-Mab binds strongly 
to the 100 kDa ce-actinin and also to ce-fodrin. 
These are detected with the antibodies to o~-actinin 
and calf lens fodrin, respectively (fig.2, lanes 
12,13). In other chicken and mammalian tissues 
(brain, smooth muscle, cardiac muscle, intestine) 
immunoblotting revealed that our Mab only cross- 
reacts with the 240 kDa c~-fodrin in addition to oe- 
actinin (not shown). 
The published sequences [9,12,14,25] show that 
although there are highly homologous regions in 
spectrin, fodrin and o~-actinin that surround the 
SEDYG region in the repeat, a completely identical 
peptide is not present in the latter. Fig.3 compares 
some putative antigenic sites in ce-actinin where our 
Mab may bind. The amino acids DYGK (fig.3, row 
2) are homologous to the SEDYG region in cr- 
fodrin (fig.3, row 1). Similarly, the amino acids 
EDYEK (fig.3, row 3) where glycine is changed to 
glutamic acid are homologous to SEDYG. Fur- 
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Fig.3. Two proposed antibody-binding sites on chicken 
o~-actinin (amino acids 121-147, row 2 and 208-233, 
row 3) corresponding to chicken o~-fodrin (amino acids 
6-31, row 1). Putative antigenic determinants are 
boxed. 
thermore, there is a homologous tripeptide, LAS, 
present in both o~-fodrin and a,-actinin. 
4. DISCUSSION 
Early studies with polyclonal antibodies against 
mammalian spectrin failed to detect any spectrin- 
like proteins in nonerythroid cells (reviews [5-7]). 
This has been generally thought o be due to the 
complex nature of spectrin's immunologic reactivi- 
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Fig.2. Immunoblotting analysis of SDS-PAGE separated chicken and human polypeptides recognized by the IV12DG9 
Mab. Amido black was used for protein staining (lanes 1,3,6,10). Immunostaining with the IV12DG9-Mab revealed 
both ce- and fl-spectrins of human red blood cells (lane 2) but only ce-spectrin in chicken erythroid cells (lane 4) as also 
anti-calf lens fodrin antibodies (lane 5).Among chicken fibroblast polypeptides the Mab identified ce-fodrin (lane 7) 
as did the antibodies tocalf lens fodrin (lane 8), and as well a prominent 100 kDa polypeptide also detected by the ce- 
actinin Mab (lane 9). In human fibroblasts the monoclonal ntibody also bound strongly to the prominent 100 kDa 
polypeptide and also to ce-fodrin (lane 11) whereas antibodies to calf lens fodrin identified the o~-fodrin as a distinct 
240/235 kDa doublet (lane 12) and the ce-actinin Mab revealed a similar 100 kDa polypeptide (lane 13). 
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ty [6] and to the narrow specificity of polyclonal 
antibodies [26]. Antibodies to synthetic peptides 
may in such a situation open up a new approach, 
because they are targeted to a defined sequence in 
the polypeptide [27]. Here, we have selected a con- 
served sequence of the chicken ce-fodrin repeats for 
an antigen. The highly hydrophilic nature of this 
region and its probable folding to a H-turn sug- 
gested that it might be a good immunogen [27]. 
The sequence SEDYG is repeated three times in the 
cloned fragment of chicken ce-fodrin [9] and once 
in the published fragment of human ce-spectrin [12] 
where it occurs in a peptide identical to our an- 
tigen. Although in the o~-actinin molecule there is 
only partial sequence homology with this sequence 
[14], our monoclonal antibody reacts with both ce- 
actinin and some spectrins. This sequence 
homology must indicate that the shared domains in 
c~-actinin and spectrin have very similar folds, 
otherwise the antibody would not detect hese two 
proteins. 
The identical immunoreactivities suggested to 
Lazarides and Nelson [28] that chicken ce-fodrin 
might be identical to chicken o~-spectrin. The pre- 
sent results support this possibility. However, it 
has also been suggested, mainly from analysis of 
peptide maps [8], that mammalian ce-fodrin could 
be related closely to avian o~-spectrin, whereas 
mammalian spectrins would be more distant from 
these. Interestingly, the present results would sug- 
gest that chicken o~-spectrin and o~-fodrin are close- 
ly related to mammalian erythroid o~- and 
/5'-spectrins as well as to mammalian o~-fodrin. The 
other members of the spectrin family may be more 
distinct proteins and therefore may not be revealed 
by our Mab. 
Micro filaments, microtubules, intermediate 
filaments, nuclear lamina and spectrins together 
form a fibrillar complex in the cytoplasm of 
eukaryotic cells collectively called the cytoskele- 
ton. Although all major components of the cyto- 
skeleton appear to be distinct elements, recent 
studies have revealed homologies which may in- 
dicate a common evolutionary origin. Thus, 
nuclear lamins and intermediate filaments show 
considerable cross-reactivity in immunological 
studies as well as homology in sequence com- 
parisons [29-31]. Similarly, some of the actin- 
associated proteins show similarities with actin 
itself which may suggest heir common origin [32]. 
The sequence homology between spectrins and o:- 
actinin [14], their common binding to actin [33,34] 
as well as a shared antigenic determinant found in 
this study, raise the question as to how closely 
these polypeptides are related structurally and 
functionally. Whether the Mab-binding sites might 
have any functional role in the cytoskeletal system 
remains to be established. 
ACKNOWLEDGEMENTS 
The skilful technical assistance of Ms P. Kai- 
painen, Ms S. Roine, Ms A.M. Siivonen and Ms R. 
Taavela is acknowledged. This study was sup- 
ported by grants from the Sigrid Jusdlius Founda- 
tion, the University of Helsinki, the Finnish 
Cancer Research Fund and by a research contract 
(I.V.) with the Academy of Finland. 
REFERENCES 
[1] Glenney, J.R. and Glenney, D. (1983) Cell Motil. 
3, 671-678. 
[2] Repasky, E.A., Granger, B.L. and Lazarides, E. 
(1982) Cell 29, 821-830. 
[3] lehto, V.-P. and Virtanen, I. (1983) J. Cell Biol. 
96, 703-716. 
[4] Virtanen, I., Badley, R.A., Paasivuo, R. and 
Lehto, V.-P. (1984) J. Cell Biol. 99, 1083-1091. 
[5] Bennett, V. (1985) Annu. Rev. Biochem. 54, 
273-304. 
[6] Marchesi, V.T. (1985) Annu. Rev. Cell Biol. 1, 
531-561. 
[7] Virtanen, T., Thornell, L.-E., Damjanov, I., 
Damjanov, A., Hormia, M. and Lehto, V.-P. 
(1986) in: Membrane Skeletons and Cytoskeletal- 
Membrane Associations (Bennett, V. et al. eds) 
pp.635-647, Liss, New York. 
[8] Glenney, J.R. and Glenney, P. (1984) Eur. J. Bio- 
chem. 144, 529-539. 
[9] Wasenius, V.-M., Saraste, M., Knowles, J., 
Virtanen, I. and Lehto, V.-P. (1985) EMBO J. 4, 
1425-1430. 
[10] Birkenmeier, C.S., Bodine, D.M., Repasky, E.A., 
Helfman, D.M., Hughes, S.H. and Barker, J.E. 
(1985) Proc. Natl. Acad. Sci. USA 82, 5671-5675. 
[11] MacMahon, A.P., Giebelhaus, D.H., Champion, 
J.E., Bailes, J.A., Lacey, S., Carritt, B., 
Henchman, S.K. and Moon, R.T. (1987) 
Differentiation 34, 68-78. 
[12] Speicher, D.W. and Marchesi, V.T. (1984) Nature 
311, 177-180. 
159 
Volume 224, number 1 FEBS LETTERS November 1987 
[13] Speicher, D.W. (1986) J. Cell. Biochem. 30, 
245-258. 
[14] Wasenius, V.-M., N~irv~inen, O., Lehto, V.-P. and 
Saraste, M. (1987) FEBS Lett. 221, 73-76. 
[15] Merrifield, R.B. (1964) Biochemistry 3, 1385-1390. 
[16] Sarin, U.K., Kent, B.H., Tam, J.P. and Merrifield, 
R.B. (1981)Anal. Biochem. 117, 147-157. 
[17] Liu, F., Zinnecker, M., Homaska, T. and Katz, 
D.H. (1979) Biochemistry 18, 690-697. 
[18] Luben, R.A. and M611er, M.A. (1980) Mol. 
Immunol. 17, 635-639. 
[19] K6hler, G. and Milstein, C. (1976) Eur. J. 
Immunol. 6, 511-519. 
[20] Dodge, J., Mitchell, D. and Hanahan, D. (1963) 
Arch. Biochem. Biophys. 100, 119-130. 
[21] Gratzer, W.B. (1981) Methods Enzymol. 85, 
475-480. 
[22] Feramisco, J.R. and Burridge, K. (1980) J. Biol. 
Chem. 255, 1194-1199. 
[23] Laemmli, U.K. (1970) Nature 227, 680-682. 
[24] Towbin, H., Staehelin, R. and Gordon, J. (1979) 
Proc. Natl. Acad. Sci. USA 76, 4350-4354. 
[25] Baron, M.D., Davison, M.D., Jones, P., Patel, B. 
and Critchley, D.R. (1987) J. Biol. Chem. 262, 
2558-2561. 
[26] Harris, A.S., Green, L.A.D., Ainger, K.J. and 
Morrow, J.S. (1985) Biochim. Biophys. Acta 830, 
147-158. 
[27] Westhof, E., Altschuh, D., Moras, D., Bloomer, 
A.C., Mondragon, A., Klug, A. and Van 
Regenmortel, M.H.V. (1984) Nature 311, 123-128. 
[28] Lazarides, E. and Nelson, W.G. (1982) Cell 31, 
505-508. 
[29] Franke, W.W. (1987) Cell 48, 3-4. 
[30] Parry, D.A.D., Conway, J.F. and Steinert, P.M. 
(1986) Biochem. J. 238, 305-308. 
[31] Aebi, U., Cohn, J., Buhle, L. and Gerace, L. 
(1986) Nature 323, 560-564. 
[32] Maruta, H., Knoerzer, W., Hinssen, H. and 
Isenberg, G. (1984) Nature 312, 424-429. 
[33] Weeds, A. (1982) Nature 296, 811-816. 
[34] Stossel, T.P., Chaponnier, C., Ezzell, R.M., 
Hartwig, J.H., Janmey, P.A., Kwiatkowski, D.J., 
Lind, S.E., Smith, D.B., Southwick, F.S., Yin, 
H.L. and Zaner, K.S. (1985) Annu. Rev. Cell Biol. 
1, 353-402. 
160 
